Literature DB >> 11810673

Renal T(*)(2) perfusion using an iron oxide nanoparticle contrast agent--influence of T(1) relaxation on the first-pass response.

Atle Bjørnerud1, Lars O Johansson, Håkan K Ahlström.   

Abstract

Quantitative perfusion measurements require accurate knowledge of the correlation between first-pass signal changes and the corresponding tracer concentration in tissue. In the present study, a detailed analysis of first-pass renal cortical changes in T(1) and T(*)(2) following bolus injection of the iron oxide nanoparticle NC100150 Injection was investigated in a pig model using a double-echo gradient-echo sequence. The estimated change in 1/T(*)(2) during first pass calculated from single-echo sequences was compared to the true double-echo-derived 1/T(*)(2) curves. Using a single-echo (TE = 6 ms) spoiled gradient-echo sequence, the first-pass 1/T(*)(2) response following a bolus injection of 1 mg Fe/kg of NC100150 Injection was significantly underestimated due to counteracting T(1) effects. Signal response simulations showed that the relative error in the first-pass response decreased with increasing TE and contrast agent dose. However, both the maximum TE and the maximum dose are limited by excessive cortical signal loss, and the maximum TE is further limited by high temporal resolution requirements. The problem of T(1) contamination can effectively be overcome by using a double-echo gradient-echo sequence. This yields a first-pass response that truly reflects the tissue tracer concentration, which is a critical requirement for quantitative renal perfusion assessment. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11810673     DOI: 10.1002/mrm.10058

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  1 in total

1.  Influence of blood/tissue differences in contrast agent relaxivity on tracer-based MR perfusion measurements.

Authors:  Arvid Morell; Fredrik Lennmyr; Ove Jonsson; Thomas Tovedal; Jean Pettersson; Jonas Bergquist; Vitas Zemgulis; Gunnar Myrdal Einarsson; Stefan Thelin; Håkan Ahlström; Atle Bjørnerud
Journal:  MAGMA       Date:  2014-06-28       Impact factor: 2.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.